A Comprehensive Guide to Chordoma of the Sacrum and Mobile Spine

High-Yield Summary

• Chordomas are rare, slow-growing malignant tumors arising from notochordal remnants, predominantly affecting the sacrum and mobile spine, with a predilection for local recurrence rather than distant metastasis.
• Surgical resection with wide margins remains the cornerstone of treatment; en bloc resection offers the best chance for local control and survival.
• Preoperative imaging with MRI and CT is essential to delineate tumor extent, involvement of neural elementsand vascular anatomy to guide surgical planning.
• Adjuvant radiotherapy, particularly proton beam or carbon ion therapy, improves local control in cases of positive margins or unresectable disease.
• Multidisciplinary management and meticulous surgical technique are critical to minimize morbidity, preserve neurological functionand optimize oncologic outcomes.

Clinical Fundamentals

Relevant Anatomy

Chordomas arise from embryonic notochord remnants located along the axial skeleton. The sacrum and clivus are the most common sites, with the mobile spine (cervical, thoracic, lumbar) less frequently involved. The sacrum’s complex anatomy includes sacral nerve roots critical for bowel, bladderand lower extremity function. The mobile spine’s proximity to the spinal cord and vertebral arteries demands precise anatomical knowledge to avoid catastrophic neurological injury.

Biomechanics

The sacrum transmits axial loads from the spine to the pelvis; extensive resection can destabilize the pelvic ring, necessitating reconstruction. The mobile spine’s segmental stability depends on vertebral bodies, discsand posterior elements; chordoma resection often requires stabilization to prevent deformity and preserve function.

Epidemiology

Chordomas represent 1-4% of primary bone tumors, with an incidence of approximately 0.08 per 100,000 per year. Peak incidence occurs in the 5th to 7th decades. Male predominance is noted. Recurrence rates exceed 50% without wide resection, underscoring the tumor’s locally aggressive nature.

Classification & Diagnosis

Diagnostic Pearls

• MRI is the modality of choice for soft tissue and neural involvement; chordomas typically show low-to-intermediate T1 and high T2 signal with heterogeneous enhancement.
• CT defines bony destruction and calcifications, aiding surgical planning.
• Biopsy must be carefully planned to avoid contamination of uninvolved compartments; percutaneous core biopsy under image guidance is preferred.
• Common pitfall: misdiagnosis as benign notochordal cell tumor or chondrosarcoma; immunohistochemistry (brachyury positivity) confirms chordoma.

Decision-Making Algorithm

Surgical Approach Selection

• Sacral chordomas: Posterior approach with possible combined anterior approach for high lesions (above S2) or anterior vascular control.
• Mobile spine chordomas: Anterior, posterioror combined approaches depending on tumor location, extentand need for reconstruction.
• Instrumentation: Segmental fixation is often required post-resection to restore stability.

Surgical Mastery & Pearls

Step-by-Step Conceptual Overview

1. Preoperative Planning: Detailed imaging review, multidisciplinary discussionand patient counseling regarding neurological risks and reconstruction.
2. Patient Positioning: Prone for sacral tumors; prone or lateral decubitus for mobile spine depending on approach.
3. Exposure: Wide exposure to visualize tumor margins and critical neurovascular structures; use intraoperative neuromonitoring.
4. Tumor Resection: Aim for en bloc resection with negative margins; piecemeal resection only if en bloc is not feasible.
5. Neural Element Management: Sacrifice of sacral nerve roots below S2 may be necessary; preserve S2 and above to maintain function.
6. Reconstruction: Pelvic ring stabilization with iliac screws and rods for sacral defects; anterior column reconstruction with cages or allograft for mobile spine.
7. Hemostasis: Anticipate significant blood loss; preoperative embolization may reduce intraoperative bleeding.
8. Closure: Meticulous soft tissue coverage to prevent wound complications.

Intraoperative Red Flags

• Uncontrolled bleeding from presacral venous plexus or iliac vessels.
• Loss of neuromonitoring signals indicating impending neurological injury.
• Difficulty achieving clear margins due to tumor adherence to critical structures.
• Inadequate exposure compromising visualization of tumor boundaries.

Evidence-Based Synthesis

Recent literature reinforces that en bloc resection with negative margins remains the single most important prognostic factor for local control and survival. Studies comparing piecemeal versus en bloc resection demonstrate significantly higher recurrence rates with intralesional excision. The advent of advanced proton and carbon ion radiotherapy has improved local control in cases with positive margins or unresectable tumors, though randomized trials are lacking due to rarity.

Controversy persists regarding the extent of sacral nerve root sacrifice; emerging data suggest that preserving bilateral S2 roots when possible optimizes functional outcomes without compromising oncologic control. The role of neoadjuvant therapies remains investigational, with some centers exploring targeted molecular agents based on chordoma genomics.

Multicenter registries and prospective cohorts have highlighted the importance of multidisciplinary care integrating surgical, radiationand medical oncology expertise to tailor individualized treatment plans.

Master Class Pro-Tip

Mastery in chordoma surgery hinges on preoperative margin mapping using the WBB classification combined with intraoperative navigation and neuromonitoring. Surgeons who integrate these tools can achieve true en bloc resections while preserving critical neurological function. Anticipate and plan for complex pelvic reconstruction early; collaboration with plastic surgery for vascularized soft tissue coverage reduces wound complications and improves long-term outcomes. Finally, cultivate a low threshold for staged procedures in extensive tumors to optimize patient safety and surgical precision.

Last Updated on July 26, 2026 by OrthoNet AI